Article
Risk Profile of the RET A883F Germline Mutation: An International Collaborative Study.
The Journal of clinical endocrinology and metabolism - 1 Jun 2017
Mathiesen Jes Sloth, Habra Mouhammed Amir, Bassett John Howard Duncan, Choudhury Sirazum Mubin, Balasubramanian Sabapathy Prakash, Howlett Trevor A, Robinson Bruce G, Gimenez-Roqueplo Anne-Paule, Castinetti Frederic, Vestergaard Peter, Frank-Raue Karin
Abstract excerpt
Context: The A883F germline mutation of the rearranged during transfection (RET) proto-oncogene causes multiple endocrine neoplasia 2B. In the revised American Thyroid Association (ATA) guidelines for the management of medullary thyroid carcinoma (MTC), the A883F mutation has been reclassified from the highest to the high-risk level, although no well-defined risk profile for this mutation exists. Objective: To...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
